CH
CALA

CVI Holdings’s Calithera Biosciences, Inc CALA Stock Holding History

CVI Holdings’s Portfolio CALA Stock Details CALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-42,162
Closed -$3.29M – 72
2019
Q2 		$3.29M Buy
+42,162
New +$4.79M 3.8% 7

Other funds holding CALA

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

CVI Holdings's CALA Position: Q3 2019 in Review

CVI Holdings sold out of Calithera Biosciences, Inc (CALA) in Q3 2019, closing a stake of 42,162 shares — an estimated $3.29M sold.

CVI Holdings first reported a position in CALA in Q2 2019 and held it in 1 quarter. The position peaked at $3.29M in Q2 2019. 85 funds tracked by Wall St. Rank hold CALA as of Q3 2019.

  • CVI Holdings reported no remaining Calithera Biosciences, Inc position as of Q3 2019 after selling out during the quarter.
  • CVI Holdings sold 42,162 Calithera Biosciences, Inc shares in Q3 2019, an estimated $3.29M.
  • CVI Holdings first reported a position in Calithera Biosciences, Inc in Q2 2019 and held it in 1 quarter.
  • CVI Holdings's Calithera Biosciences, Inc position peaked at $3.29M in Q2 2019.
  • 85 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q3 2019.

Based on CVI Holdings's 13F filing for Q3 2019, filed 14 Nov 2019.